Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · Real-Time Price · USD

24.57

-0.36 (-1.44%)

At close: Aug 26, 2026, 4:00 PM EDT

24.35

-0.22 (-0.90%)

After-hours: Aug 26, 2026, 5:20 PM EDT

Denali Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3.6	-	-	330.53	108.46	48.66
Revenue Growth	-	-	-	204.74%	122.89%	-85.50%
Cost of Revenue	400.81	418.78	396.44	423.88	358.73	265.35
Gross Profit	-397.21	-418.78	-396.44	-93.35	-250.27	-216.69
Selling, General & Admin	144.74	136.56	105.44	103.35	90.48	79.06
Operating Expenses	144.74	136.56	105.44	103.35	90.48	79.06
Operating Income	-541.95	-555.34	-501.88	-196.7	-340.74	-295.75
Interest & Investment Income	24.98	32.65	29.52	7.55	13.14	13.34
EBT Excluding Unusual Items	-516.97	-522.69	-472.36	-189.15	-327.61	-282.41
Gain (Loss) on Sale of Investments	6.37	10.25	35.12	43.95	1.64	-8.75
Gain (Loss) on Sale of Assets	-	-	14.54	-	-	-
Pretax Income	-511.35	-512.44	-422.71	-145.19	-325.97	-291.16
Income Tax Expense	0.1	0.1	0.07	0.03	0.02	-0.58
Net Income	-511.45	-512.54	-422.77	-145.22	-325.99	-290.58
Net Income to Common	-511.45	-512.54	-422.77	-145.22	-325.99	-290.58
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	180	173	164	137	126	122
Shares Outstanding (Diluted)	180	173	164	137	126	122
Shares Change	5.80%	4.97%	19.73%	9.43%	3.30%	7.83%
EPS (Basic)	-2.83	-2.97	-2.57	-1.06	-2.60	-2.39
EPS (Diluted)	-2.83	-2.97	-2.57	-1.06	-2.60	-2.39
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-437.46	-422.1	-363.61	-370.93	-262.55	-219.89
Free Cash Flow Per Share	-2.42	-2.44	-2.21	-2.70	-2.09	-1.81
Gross Margin	-	-	-	-28.24%	-230.74%	-
Operating Margin	-15037.38%	-	-	-59.51%	-314.16%	-607.78%
Profit Margin	-14191.20%	-	-	-43.94%	-300.56%	-597.15%
Free Cash Flow Margin	-12138.10%	-	-	-112.22%	-242.06%	-451.88%
EBITDA	-526.06	-540.53	-492.89	-187.87	-330.36	-287.16
EBITDA Margin	-	-	-	-56.84%	-	-
D&A For EBITDA	15.89	14.81	8.99	8.83	10.38	8.59
EBIT	-541.95	-555.34	-501.88	-196.7	-340.74	-295.75
EBIT Margin	-	-	-	-59.51%	-	-
Revenue as Reported	3.6	-	-	330.53	108.46	48.66

SEC Filings: 10-K · 10-Q